These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 36212394)

  • 1. A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art.
    Pinkiewicz M; Pinkiewicz M; Walecki J; Zawadzki M
    Front Oncol; 2022; 12():950167. PubMed ID: 36212394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rechallenging Recurrent Glioblastoma with Intra-Arterial Bevacizumab with Blood Brain-Barrier Disruption Results in Radiographic Response.
    Faltings L; Kulason KO; Patel NV; Wong T; Fralin S; Li M; Schneider JR; Filippi CG; Langer DJ; Ortiz R; Boockvar JA
    World Neurosurg; 2019 Nov; 131():234-241. PubMed ID: 31351210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going.
    D'Amico RS; Khatri D; Reichman N; Patel NV; Wong T; Fralin SR; Li M; Ellis JA; Ortiz R; Langer DJ; Boockvar JA
    J Neurooncol; 2020 Apr; 147(2):261-278. PubMed ID: 32076934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival.
    Burkhardt JK; Riina H; Shin BJ; Christos P; Kesavabhotla K; Hofstetter CP; Tsiouris AJ; Boockvar JA
    World Neurosurg; 2012 Jan; 77(1):130-4. PubMed ID: 22405392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superselective intraarterial cerebral infusion of cetuximab with blood brain barrier disruption combined with Stupp Protocol for newly diagnosed glioblastoma.
    Kulason KO; Schneider JR; Chakraborty S; Filippi CG; Pramanik B; Wong T; Fralin S; Tan K; Ray A; Alter RA; Ortiz R; Demopoulos A; Langer DJ; Boockvar JA
    J Exp Ther Oncol; 2018 May; 12(3):223-229. PubMed ID: 29790314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series.
    Shin BJ; Burkhardt JK; Riina HA; Boockvar JA
    Neurosurg Clin N Am; 2012 Apr; 23(2):323-9, ix-x. PubMed ID: 22440875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of intra-arterial chemotherapy as an adjuvant treatment for glioblastoma.
    Theodotou C; Shah AH; Hayes S; Bregy A; Johnson JN; Aziz-Sultan MA; Komotar RJ
    Br J Neurosurg; 2014 Aug; 28(4):438-46. PubMed ID: 24432794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma.
    Riina HA; Fraser JF; Fralin S; Knopman J; Scheff RJ; Boockvar JA
    J Exp Ther Oncol; 2009; 8(2):145-50. PubMed ID: 20192120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durability of single dose intra-arterial bevacizumab after blood/brain barrier disruption for recurrent glioblastoma.
    Chakraborty S; Filippi CG; Burkhardt JK; Fralin S; Ray A; Wong T; Ortiz R; Langer DJ; Boockvar JA
    J Exp Ther Oncol; 2016 Nov; 11(4):261-267. PubMed ID: 27849336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessing the Role of Intra-Arterial Drug Delivery for Glioblastoma Multiforme Treatment.
    Ellis JA; Banu M; Hossain SS; Singh-Moon R; Lavine SD; Bruce JN; Joshi S
    J Drug Deliv; 2015; 2015():405735. PubMed ID: 26819758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors.
    Srinivasan VM; Lang FF; Chen SR; Chen MM; Gumin J; Johnson J; Burkhardt JK; Kan P
    J Neurointerv Surg; 2020 Feb; 12(2):197-203. PubMed ID: 31676690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraarterial drug delivery for glioblastoma mutiforme: Will the phoenix rise again?
    Joshi S; Ellis JA; Ornstein E; Bruce JN
    J Neurooncol; 2015 Sep; 124(3):333-43. PubMed ID: 26108656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial.
    Patel NV; Wong T; Fralin SR; Li M; McKeown A; Gruber D; D'Amico RS; Patsalides A; Tsiouris A; Stefanov DG; Flores O; Zlochower A; Filippi CG; Ortiz R; Langer DJ; Boockvar JA
    J Neurooncol; 2021 Nov; 155(2):117-124. PubMed ID: 34601657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity.
    Muldoon LL; Pagel MA; Netto JP; Neuwelt EA
    J Neurooncol; 2016 Feb; 126(3):447-54. PubMed ID: 26694547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme.
    Burkhardt JK; Shin BJ; Schlaff CD; Riina H; Boockvar JA
    J Exp Ther Oncol; 2011; 9(3):183-6. PubMed ID: 22070049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II trial of superselective arterial 5-FU infusion with concomitant external beam radiation for patients with either anaplastic astrocytoma or glioblastoma multiforme.
    Larner JM; Kersh CR; Constable WC; Kline P; Ferguson R; Short R; Jane JA
    Am J Clin Oncol; 1991 Dec; 14(6):514-8. PubMed ID: 1659783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Republished: Real-time MRI guidance for intra-arterial drug delivery in a patient with a brain tumor: technical note.
    Zawadzki M; Walecki J; Kostkiewicz B; Kostyra K; Pearl MS; Solaiyappan M; Walczak P; Janowski M
    J Neurointerv Surg; 2019 Aug; 11(8):e3. PubMed ID: 31123186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time MRI guidance for intra-arterial drug delivery in a patient with a brain tumor: technical note.
    Zawadzki M; Walecki J; Kostkiewicz B; Kostyra K; Pearl MS; Solaiyappan M; Walczak P; Janowski M
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30679227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A murine model of targeted infusion for intracranial tumors.
    Kim M; Barone TA; Fedtsova N; Gleiberman A; Wilfong CD; Alosi JA; Plunkett RJ; Gudkov A; Skitzki JJ
    J Neurooncol; 2016 Jan; 126(1):37-45. PubMed ID: 26376657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.